Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations
-
Published:2022-08
Issue:
Volume:74
Page:103533
-
ISSN:1773-2247
-
Container-title:Journal of Drug Delivery Science and Technology
-
language:en
-
Short-container-title:Journal of Drug Delivery Science and Technology
Author:
Kumar MohitORCID,
Dogra RaghavORCID,
Mandal Uttam KumarORCID
Subject
Pharmaceutical Science
Reference227 articles.
1. Efficacy and landscape of Covid-19 vaccines: a review article;de Azevedo;Rev. Assoc. Med. Bras.,2021
2. Thermosensitive nasal in situ gelling systems of rufinamide formulated using modified tamarind seed xyloglucan for direct nose-to-brain delivery: design, physical characterization, and in vivo evaluation;V Dalvi;J. Pharm. Investig.,2021
3. Direct delivery of ANA-TA9, a peptide capable of aβ hydrolysis, to the brain by intranasal administration;Hatakawa;Pharmaceutics,2021
4. Respiratory nasal mucosa in chronic rhinosinusitis with nasal polyps versus COVID-19: histopathology, electron microscopy analysis and assessing of tissue interleukin-33;Jeican;J. Clin. Med.,2021
5. Physiology and pathophysiology of human airway mucus;Hill;Physiol. Rev.,2022
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献